University of Chicago-University of Illinois College of Medicine at Chicago Program

Program Identity & Fit

This is a research-intensive academic radiation oncology program built on a multi-institutional partnership between the University of Chicago Medicine and University of Illinois/UI Health, giving residents exposure to both a quaternary academic cancer center and a public safety-net hospital system. The curriculum dedicates an entire PGY-4 year to protected research (basic science or clinical/outcomes, with an option to pursue an MSCP degree), reflecting the department's stated identity of training residents as "oncologists first and radiotherapists second" through case-based Monday Morning Conference and disease-site-organized didactics. Faculty research infrastructure is substantial, spanning tumor-immune interactions, metastasis biology, DNA repair mechanisms, and novel imaging (EPR), with residents integrated into labs led by nationally recognized investigators like Weichselbaum. Alumni outcomes show a strong pull toward academic and university-affiliated first jobs (Chicago, Northwestern, Mayo, UCSF, UCSD, Dartmouth, Vanderbilt), though some graduates enter community and hybrid academic-community practices, indicating the program values scholarly rigor and independent research capability alongside clinical competence.